(Q37004657)

17 August 2017

1 reference

title

Samarium lexidronam (153Sm-EDTMP): skeletal radiation for osteoblastic bone metastases and osteosarcoma (English)

1 reference

samarium (153sm) lexidronam

17 August 2017

0 references

1 reference

Pete Anderson

1

1 reference

17 August 2017

Rodolfo Nuñez

series ordinal

2

1 reference

17 August 2017

publication date

1 November 2007

1 reference

Expert Review of Anticancer Therapy

17 August 2017

published in

1 reference

17 August 2017

volume

7

1 reference

17 August 2017

issue

11

1 reference

17 August 2017

page(s)

1517-1527

1 reference

Bone metastases: approaches to management

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Palliation and supportive care in radiation medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Radiopharmaceuticals for the palliation of painful bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Samarium for osteoblastic bone metastases and osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Bone seeking radiopharmaceuticals for palliation of pain in cancer patients with osseous metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Targeted and systemic radiotherapy in the treatment of bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Uptake of bone-seekers is solely associated with mineralisation! A study with 99mTc-MDP, 153Sm-EDTMP and 18F-fluoride on osteoblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Facile access to 154Eu, a new reference source for calibration in gamma ray spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Analysis of urine samples from metastatic bone cancer patients administered 153Sm-EDTMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Samarium 153Sm lexidronam

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Gemcitabine radiosensitization after high-dose samarium for osteoblastic osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Bisphosphonates: mode of action and pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Metastatic bone disease in breast cancer: the patient's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Bisphosphonates in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Bisphosphonates and radiation therapy for palliation of metastatic bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

The use of bisphosphonates in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Managing metastatic bone pain: the role of bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Effectiveness of bisphosphonates on bone pain and quality of life in breast cancer patients with metastatic bone disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Zoledronic acid in the management of metastatic bone disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Zoledronic acid is effective in preventing and delaying skeletal events in patients with bone metastases secondary to genitourinary cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Lack of effect of a bisphosphonate (pamidronate disodium) infusion on subsequent skeletal uptake of Sm-153 EDTMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

A comparative study of samarium-153-ethylenediaminetetramethylene phosphonic acid with pamidronate disodium in the treatment of patients with painful metastatic bone cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Efficacy and safety of repeated samarium-153 lexidronam treatment in a patient with prostate cancer and metastatic bone pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

A phase II study of treatment of painful multifocal skeletal metastases with single and repeated dose samarium-153 ethylenediaminetetramethylene phosphonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Safety and efficacy of repeat administration of samarium Sm-153 lexidronam to patients with metastatic bone pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Pain flare in patients with bone metastases after palliative radiotherapy--a nested randomized control trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

A multicentre observational study of radionuclide therapy in patients with painful bone metastases of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Dosimetry and toxicity of Quadramet for bone marrow ablation in multiple myeloma and other haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

153Sm EDTMP for bone marrow ablation prior to stem cell transplantation for haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Outcome of myeloablative allogeneic stem cell transplantation in multiple myeloma with a 153Sm-EDTMP-based preparative regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Low toxicity and efficacy of (153)samarium-EDTMP and melphalan as a conditioning regimen for secondary acute myelogenous leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Radioisotopes for the palliation of metastatic bone cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Treatment of bone pain secondary to metastases using samarium-153-EDTMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Targeted therapies for soft-tissue sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Anticancer activities of histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

DNA methylation as a therapeutic target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Molecular therapy in the microRNA era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Knowledge of epigenetic influence for prostate cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Improving outcomes in difficult bone cancers using multimodality therapy, including radiation: physician and nursing perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Painful metastases involving bone: percutaneous image-guided cryoablation--prospective trial interim analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Image-guided ablation of painful metastatic bone tumors: a new and effective approach to a difficult problem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

The benefit of bone-seeking radiopharmaceuticals in the treatment of metastatic bone pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Cancer therapy using bone-seeking isotopes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Rhenium-188-HEDP in the palliative treatment of bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

Systemic radionuclide therapy in pain palliation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

High-linear energy transfer irradiation targeted to skeletal metastases by the alpha-emitter 223Ra: adjuvant or alternative to conventional modalities?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

First clinical experience with alpha-emitting radium-223 in the treatment of skeletal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1517

10.1586/14737140.7.11.1517

21 January 2018

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/p46tr26jcvfazfhlhmzjt2rku4

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_p46tr26jcvfazfhlhmzjt2rku4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/p46tr26jcvfazfhlhmzjt2rku4

mapped directly with Wikidata item

30 July 2022

based on heuristic

https://api.fatcat.wiki/v0/release/p46tr26jcvfazfhlhmzjt2rku4

1 reference